173 related articles for article (PubMed ID: 34414103)
1. Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis.
Wang CQ; Huang XR; He M; Zheng XT; Jiang H; Chen Q; Fan TY; Zhan L; Ling J; Feng JH; Xiao X; Chen XF; Xiao Z
Front Oncol; 2021; 11():649999. PubMed ID: 34414103
[TBL] [Abstract][Full Text] [Related]
2. The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis.
Wang CQ; Xu J; Jiang H; Zheng XT; Zhang Y; Huang XR; She F; Fan TY; Zhan L; Feng JH; Gong QH; Xiao X; Chen XF; Xiao Z
Phytomedicine; 2023 Jul; 115():154847. PubMed ID: 37149965
[TBL] [Abstract][Full Text] [Related]
3. Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials.
Xiao Z; Jiang Y; Chen XF; Wang CQ; Zheng XT; Xu WH; Zou XX; Zhou JM; Yang YH; Hu SS; Shan LJ; Cai QY; Tang YH; Feng JH; Xiao X
Phytomedicine; 2020 Jun; 76():153260. PubMed ID: 32535483
[TBL] [Abstract][Full Text] [Related]
4. Intrapleural Perfusion With Staphylococcal Enterotoxin C for Malignant Pleural Effusion: A Clustered Systematic Review and Meta-Analysis.
Jiang H; Yang XM; Wang CQ; Xu J; Huang J; Feng JH; Chen XF; Chen K; Zhan L; Xiao X; Xiao Z
Front Med (Lausanne); 2022; 9():816973. PubMed ID: 35547209
[TBL] [Abstract][Full Text] [Related]
5. The intrapleural administration with thymic peptides in malignant pleural effusion: A clusteredsystematicreview and meta-analysis.
Wang CQ; Shen YS; Chen XF; Jiang H; Yang XM; Fan TY; Li SG; Yang P; Zhan L; Chen R; Feng JH; Xiao X; Xiao Z
Int Immunopharmacol; 2022 Jun; 107():108688. PubMed ID: 35293322
[TBL] [Abstract][Full Text] [Related]
6. Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials.
Xu YF; Chen YR; Bu FL; Huang YB; Sun YX; Li CY; Sellick J; Liu JP; Qin DM; Liu ZL
Front Oncol; 2022; 12():942941. PubMed ID: 36203451
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
[TBL] [Abstract][Full Text] [Related]
8. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
Chen L; Zhu X; Li D; Cai X
J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
[TBL] [Abstract][Full Text] [Related]
9. The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non-small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials.
Wang CQ; Zheng XT; Chen XF; Jiang H; Huang J; Jiang Y; Hu SS; Huang XR; Liu SY; Gong QH; Feng JH; Xiao X; Li XF; Xiao Z
Front Pharmacol; 2021; 12():582447. PubMed ID: 34122057
[No Abstract] [Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial.
Zhang R; Wang ZY; Li YH; Lu YH; Wang S; Yu WX; Zhao H
Lancet; 2016 Oct; 388 Suppl 1():S95. PubMed ID: 27968915
[TBL] [Abstract][Full Text] [Related]
13. Rh-endostatin Concomitant with Chemotherapy Versus Single Agent Chemotherapy for Treating Soft Tissue and Bone Sarcomas: A Systematic Review and Meta-Analysis.
Ma Z; Guo L; Cui X; Liu H; Liu L
J Pharm Pharm Sci; 2018; 21(1):386-397. PubMed ID: 30352660
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
Hu Y; Zhou Z; Luo M
Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
[TBL] [Abstract][Full Text] [Related]
17. Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.
Wang Z; Zhang H; Zhou C; Long X; Guan R; Yang N; Zhang Y
Cancer Med; 2019 Apr; 8(4):1434-1441. PubMed ID: 30762300
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases.
Zhou Y; Gao Y; Zhang N; Li X; Wang H; Wang S; Liu J; Gao H; Wang H
J Thorac Dis; 2021 Feb; 13(2):1100-1105. PubMed ID: 33717583
[TBL] [Abstract][Full Text] [Related]
19. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
